VSL#3

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
BACKGROUND & AIMS Probiotics can maintain ulcerative colitis (UC) in remission effectively, but little is known of their ability… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Nonalcoholic fatty liver disease (NAFLD) and its advanced stage, nonalcoholic steatohepatitis (NASH), are the most common causes… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2009
Highly Cited
2009
OBJECTIVES:Several probiotic compounds have shown promise in the therapy of ulcerative colitis (UC). However, a strong sustained… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Changes in epithelial tight junction protein expression and apoptosis increase epithelial permeability in inflammatory bowel… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Recent evidence suggests that probiotic bacteria may stabilize gut barrier function via induction of anti-microbial peptides such… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND The intestinal microbiota plays a critical role in the pathophysiology of pouchitis, a major complication after ileal… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?
Highly Cited
2005
Highly Cited
2005
OBJECTIVES To evaluate whether chronic therapy with probiotics affects plasma levels of cytokines and oxidative/nitrosative… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND AND AIMS:Intestinal bacteria have been implicated in the initiation and perpetuation of IBD; in contrast, “probiotic… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Ten to 15% of patients with pouchitis experience refractory or recurrent disease. The aim of this study was to… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
AIM To investigate the effects of a probiotic formulation, VSL#3, on gastrointestinal transit and symptoms of patients with Rome… (More)
Is this relevant?